Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Rising High: Exclusive talk with biotech company Tryp Therapeutics » 11:59
05/19/22
05/19
11:59
05/19/22
11:59
GDNSF

Goodness Growth

$1.42 /

-0.05 (-3.40%)

, ZYNE

Zynerba

/

+

, TCNNF

Trulieve Cannabis

$14.37 /

-0.135 (-0.93%)

, TLRY

Tilray

$4.94 /

+0.15 (+3.13%)

, IGC

India Globalization Capital

/

+

, GTBIF

Green Thumb Industries

$11.67 /

-0.52 (-4.27%)

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$3.48 /

+0.155 (+4.66%)

, CGC

Canopy Growth

$5.89 /

+0.3 (+5.37%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, ACB

Aurora Cannabis

$3.08 /

+0.175 (+6.02%)

, RLMD

Relmada Therapeutics

$21.30 /

-0.3 (-1.39%)

, CMPS

Compass Pathways

$8.59 /

+0.36 (+4.37%)

, ATAI

Atai Life Sciences

$4.07 /

+0.125 (+3.17%)

, TRYPF

Tryp Therapeutics

/

+

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TRYPF Tryp Therapeutics
/

+

TLRY Tilray
$4.94 /

+0.15 (+3.13%)

TCNNF Trulieve Cannabis
$14.37 /

-0.135 (-0.93%)

RLMD Relmada Therapeutics
$21.30 /

-0.3 (-1.39%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.67 /

-0.52 (-4.27%)

GDNSF Goodness Growth
$1.42 /

-0.05 (-3.40%)

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CRON Cronos Group
$3.48 /

+0.155 (+4.66%)

CMPS Compass Pathways
$8.59 /

+0.36 (+4.37%)

CGC Canopy Growth
$5.89 /

+0.3 (+5.37%)

ATAI Atai Life Sciences
$4.07 /

+0.125 (+3.17%)

ACB Aurora Cannabis
$3.08 /

+0.175 (+6.02%)

GDNSF Goodness Growth
$1.42 /

-0.05 (-3.40%)

05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
ZYNE Zynerba
/

+

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
TCNNF Trulieve Cannabis
$14.37 /

-0.135 (-0.93%)

05/12/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$50 from C$60 at Alliance Global Partners
03/31/22 Canaccord
Trulieve Cannabis price target lowered to C$65 from C$70 at Canaccord
03/30/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$60 from C$76 at Alliance Global Partners
TLRY Tilray
$4.94 /

+0.15 (+3.13%)

05/02/22 Alliance Global Partners
Tilray price target lowered to $5.50 from $8 at Alliance Global Partners
04/20/22 Barclays
Tilray price target lowered to $4.50 from $8.50 at Barclays
04/06/22 MKM Partners
Tilray margins contracted despite cost savings, says MKM Partners
04/06/22 Benchmark
Tilray fiscal Q3 results 'disappointing,' says Benchmark
IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.67 /

-0.52 (-4.27%)

05/05/22 Alliance Global Partners
Green Thumb price target lowered to C$38 from C$40 at Alliance Global
05/05/22 Craig-Hallum
Green Thumb Industries price target lowered to $25 from $35 at Craig-Hallum
05/05/22 Needham
Green Thumb Industries price target lowered to $26 from $33 at Needham
CANN General Cannabis
/

+

CRON Cronos Group
$3.48 /

+0.155 (+4.66%)

05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
CGC Canopy Growth
$5.89 /

+0.3 (+5.37%)

05/20/22 Alliance Global Partners
Canopy Growth price target lowered to C$8 from C$11 at Alliance Global Partners
04/04/22 Morgan Stanley
Constellation Brands price target lowered to $294 from $299 at Morgan Stanley
03/22/22 Barclays
Canopy Growth downgraded to Underweight from Equal Weight at Barclays
CTST CannTrust
/

+

CVSI CV Sciences
/

+

ACB Aurora Cannabis
$3.08 /

+0.175 (+6.02%)

05/16/22 CIBC
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC
05/13/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
RLMD Relmada Therapeutics
$21.30 /

-0.3 (-1.39%)

05/09/22 Oppenheimer
Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer
12/20/21 SVB Leerink
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
CMPS Compass Pathways
$8.59 /

+0.36 (+4.37%)

02/28/22 Canaccord
Compass Pathways price target lowered to $78 from $80 at Canaccord
11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
11/09/21 Citi
Citi says Compass Pathways selloff overdone, ups price target to $70
11/09/21 Cantor Fitzgerald
Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald
ATAI Atai Life Sciences
$4.07 /

+0.125 (+3.17%)

05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
11/30/21
Fly Intel: Top five analyst initiations
TRYPF Tryp Therapeutics
/

+

08/26/21 Ladenburg
Tryp Therapeutics initiated with a Buy at Ladenburg
ZYNE Zynerba
/

+

TLRY Tilray
$4.94 /

+0.15 (+3.13%)

TCNNF Trulieve Cannabis
$14.37 /

-0.135 (-0.93%)

RLMD Relmada Therapeutics
$21.30 /

-0.3 (-1.39%)

GTBIF Green Thumb Industries
$11.67 /

-0.52 (-4.27%)

CVSI CV Sciences
/

+

CRON Cronos Group
$3.48 /

+0.155 (+4.66%)

CMPS Compass Pathways
$8.59 /

+0.36 (+4.37%)

CGC Canopy Growth
$5.89 /

+0.3 (+5.37%)

ATAI Atai Life Sciences
$4.07 /

+0.125 (+3.17%)

ACB Aurora Cannabis
$3.08 /

+0.175 (+6.02%)

  • 09
    Dec
  • 18
    Jun
GDNSF Goodness Growth
$1.42 /

-0.05 (-3.40%)

GDNSF Goodness Growth
$1.42 /

-0.05 (-3.40%)

CRON Cronos Group
$3.48 /

+0.155 (+4.66%)

CGC Canopy Growth
$5.89 /

+0.3 (+5.37%)

TLRY Tilray
$4.94 /

+0.15 (+3.13%)

CRON Cronos Group
$3.48 /

+0.155 (+4.66%)

CGC Canopy Growth
$5.89 /

+0.3 (+5.37%)

ATAI Atai Life Sciences
$4.07 /

+0.125 (+3.17%)

ACB Aurora Cannabis
$3.08 /

+0.175 (+6.02%)

Over a week ago
Options
Tilray call volume above normal and directionally bullish » 10:45
05/16/22
05/16
10:45
05/16/22
10:45
TLRY

Tilray

$4.94 /

+0.39 (+8.58%)

Bullish option flow…

Bullish option flow detected in Tilray with 90,347 calls trading, 6x expected, and implied vol increasing over 10 points to 102.41%. May-22 5.5 calls and May-22 6 calls are the most active options, with total volume in those strikes near 44,500 contracts. The Put/Call Ratio is 0.08. Earnings are expected on July 27th.

ShowHide Related Items >><<
TLRY Tilray
$4.94 /

+0.39 (+8.58%)

TLRY Tilray
$4.94 /

+0.39 (+8.58%)

05/02/22 Alliance Global Partners
Tilray price target lowered to $5.50 from $8 at Alliance Global Partners
04/20/22 Barclays
Tilray price target lowered to $4.50 from $8.50 at Barclays
04/06/22 MKM Partners
Tilray margins contracted despite cost savings, says MKM Partners
04/06/22 Benchmark
Tilray fiscal Q3 results 'disappointing,' says Benchmark
TLRY Tilray
$4.94 /

+0.39 (+8.58%)

TLRY Tilray
$4.94 /

+0.39 (+8.58%)

TLRY Tilray
$4.94 /

+0.39 (+8.58%)

TLRY Tilray
$4.94 /

+0.39 (+8.58%)

On The Fly
Rising High: Exclusive talk with cannabis REIT NewLake Capital » 11:42
05/12/22
05/12
11:42
05/12/22
11:42
RLMD

Relmada Therapeutics

$18.51 /

-0.07 (-0.38%)

, CMPS

Compass Pathways

$7.03 /

+0.23 (+3.38%)

, ATAI

Atai Life Sciences

$3.32 /

+0.19 (+6.07%)

, ZYNE

Zynerba

/

+

, TCNNF

Trulieve Cannabis

$13.60 /

-0.43 (-3.06%)

, TLRY

Tilray

$4.43 /

+0.37 (+9.11%)

, IGC

India Globalization Capital

/

+

, GTBIF

Green Thumb Industries

$11.76 /

+0.05 (+0.43%)

, GDNSF

Goodness Growth

$1.49 /

-0.032 (-2.11%)

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$3.14 /

+0.15 (+5.02%)

, CGC

Canopy Growth

$5.47 /

+0.49 (+9.84%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, ACB

Aurora Cannabis

$2.47 /

+0.175 (+7.64%)

, NLCP

NewLake Capital Partners

$19.88 /

+0.03 (+0.15%)

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TLRY Tilray
$4.43 /

+0.37 (+9.11%)

TCNNF Trulieve Cannabis
$13.60 /

-0.43 (-3.06%)

RLMD Relmada Therapeutics
$18.51 /

-0.07 (-0.38%)

NLCP NewLake Capital Partners
$19.88 /

+0.03 (+0.15%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.76 /

+0.05 (+0.43%)

GDNSF Goodness Growth
$1.49 /

-0.032 (-2.11%)

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CRON Cronos Group
$3.14 /

+0.15 (+5.02%)

CMPS Compass Pathways
$7.03 /

+0.23 (+3.38%)

CGC Canopy Growth
$5.47 /

+0.49 (+9.84%)

ATAI Atai Life Sciences
$3.32 /

+0.19 (+6.07%)

ACB Aurora Cannabis
$2.47 /

+0.175 (+7.64%)

RLMD Relmada Therapeutics
$18.51 /

-0.07 (-0.38%)

05/09/22 Oppenheimer
Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer
12/20/21 SVB Leerink
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
CMPS Compass Pathways
$7.03 /

+0.23 (+3.38%)

02/28/22 Canaccord
Compass Pathways price target lowered to $78 from $80 at Canaccord
11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
11/09/21 Citi
Citi says Compass Pathways selloff overdone, ups price target to $70
11/09/21 Cantor Fitzgerald
Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald
ATAI Atai Life Sciences
$3.32 /

+0.19 (+6.07%)

04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
11/30/21
Fly Intel: Top five analyst initiations
11/30/21 Maxim
Atai Life Sciences initiated with a Buy at Maxim
ZYNE Zynerba
/

+

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
TCNNF Trulieve Cannabis
$13.60 /

-0.43 (-3.06%)

05/12/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$50 from C$60 at Alliance Global Partners
03/31/22 Canaccord
Trulieve Cannabis price target lowered to C$65 from C$70 at Canaccord
03/30/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$60 from C$76 at Alliance Global Partners
TLRY Tilray
$4.43 /

+0.37 (+9.11%)

05/02/22 Alliance Global Partners
Tilray price target lowered to $5.50 from $8 at Alliance Global Partners
04/20/22 Barclays
Tilray price target lowered to $4.50 from $8.50 at Barclays
04/06/22 MKM Partners
Tilray margins contracted despite cost savings, says MKM Partners
04/06/22 Benchmark
Tilray fiscal Q3 results 'disappointing,' says Benchmark
IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.76 /

+0.05 (+0.43%)

05/05/22 Alliance Global Partners
Green Thumb price target lowered to C$38 from C$40 at Alliance Global
05/05/22 Craig-Hallum
Green Thumb Industries price target lowered to $25 from $35 at Craig-Hallum
05/05/22 Needham
Green Thumb Industries price target lowered to $26 from $33 at Needham
GDNSF Goodness Growth
$1.49 /

-0.032 (-2.11%)

05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
CANN General Cannabis
/

+

CRON Cronos Group
$3.14 /

+0.15 (+5.02%)

05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
CGC Canopy Growth
$5.47 /

+0.49 (+9.84%)

04/04/22 Morgan Stanley
Constellation Brands price target lowered to $294 from $299 at Morgan Stanley
03/22/22 Barclays
Canopy Growth downgraded to Underweight from Equal Weight at Barclays
03/01/22 Barclays
Canopy Growth price target lowered to $9 from $14 at Barclays
CTST CannTrust
/

+

CVSI CV Sciences
/

+

ACB Aurora Cannabis
$2.47 /

+0.175 (+7.64%)

05/13/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
02/03/22 CIBC
Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC
NLCP NewLake Capital Partners
$19.88 /

+0.03 (+0.15%)

03/21/22 Ladenburg
NewLake Capital price target lowered to $39.50 from $44 at Ladenburg
09/08/21 Compass Point
NewLake Capital Partners initiated with a Buy at Compass Point
09/07/21 Ladenburg
NewLake Capital Partners initiated with a Buy at Ladenburg
ZYNE Zynerba
/

+

TLRY Tilray
$4.43 /

+0.37 (+9.11%)

TCNNF Trulieve Cannabis
$13.60 /

-0.43 (-3.06%)

RLMD Relmada Therapeutics
$18.51 /

-0.07 (-0.38%)

NLCP NewLake Capital Partners
$19.88 /

+0.03 (+0.15%)

GTBIF Green Thumb Industries
$11.76 /

+0.05 (+0.43%)

CVSI CV Sciences
/

+

CRON Cronos Group
$3.14 /

+0.15 (+5.02%)

CMPS Compass Pathways
$7.03 /

+0.23 (+3.38%)

CGC Canopy Growth
$5.47 /

+0.49 (+9.84%)

ATAI Atai Life Sciences
$3.32 /

+0.19 (+6.07%)

ACB Aurora Cannabis
$2.47 /

+0.175 (+7.64%)

  • 09
    Dec
  • 18
    Jun
ZYNE Zynerba
/

+

RLMD Relmada Therapeutics
$18.51 /

-0.07 (-0.38%)

NLCP NewLake Capital Partners
$19.88 /

+0.03 (+0.15%)

CRON Cronos Group
$3.14 /

+0.15 (+5.02%)

CGC Canopy Growth
$5.47 /

+0.49 (+9.84%)

TLRY Tilray
$4.43 /

+0.37 (+9.11%)

CRON Cronos Group
$3.14 /

+0.15 (+5.02%)

CGC Canopy Growth
$5.47 /

+0.49 (+9.84%)

ATAI Atai Life Sciences
$3.32 /

+0.19 (+6.07%)

ACB Aurora Cannabis
$2.47 /

+0.175 (+7.64%)

Hot Stocks
Tilray announces expansion of Good Supply's cannabis portfolio » 07:37
05/12/22
05/12
07:37
05/12/22
07:37
TLRY

Tilray

$4.06 /

-0.225 (-5.25%)

Tilray Brands announced…

Tilray Brands announced the expansion of Good Supply's cannabis portfolio with the launch of new high-potency products including liquid wax vapes and exclusive new flower strains that will be available in select markets across Canada.

ShowHide Related Items >><<
TLRY Tilray
$4.06 /

-0.225 (-5.25%)

TLRY Tilray
$4.06 /

-0.225 (-5.25%)

05/02/22 Alliance Global Partners
Tilray price target lowered to $5.50 from $8 at Alliance Global Partners
04/20/22 Barclays
Tilray price target lowered to $4.50 from $8.50 at Barclays
04/06/22 MKM Partners
Tilray margins contracted despite cost savings, says MKM Partners
04/06/22 Benchmark
Tilray fiscal Q3 results 'disappointing,' says Benchmark
TLRY Tilray
$4.06 /

-0.225 (-5.25%)

TLRY Tilray
$4.06 /

-0.225 (-5.25%)

TLRY Tilray
$4.06 /

-0.225 (-5.25%)

TLRY Tilray
$4.06 /

-0.225 (-5.25%)

Upgrade
CIBC upgrades Cronos to buy on 'multiple reasons for optimism' » 11:34
05/11/22
05/11
11:34
05/11/22
11:34
CRON

Cronos Group

$3.11 /

-0.075 (-2.35%)

As reported earlier, CIBC…

As reported earlier, CIBC analyst John Zamparo upgraded Cronos Group to Outperformer from Neutral with an unchanged price target of $4.50. The shares provide "downside protection and upside from a potential continuation of vastly improved results," Zamparo tells investors in a research note post the Q1 results. The analyst sees "multiple reasons for optimism," saying Cronos still has $1B of net cash, its valuation "looks attractive," and its path to profitability took a "significant step forward" in Q1.

ShowHide Related Items >><<
CRON Cronos Group
$3.11 /

-0.075 (-2.35%)

CRON Cronos Group
$3.11 /

-0.075 (-2.35%)

05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
05/09/22 Raymond James
Cronos Group price target raised to $6 from $5 at Raymond James
CRON Cronos Group
$3.11 /

-0.075 (-2.35%)

CRON Cronos Group
$3.11 /

-0.075 (-2.35%)

CRON Cronos Group
$3.11 /

-0.075 (-2.35%)

CRON Cronos Group
$3.11 /

-0.075 (-2.35%)

Upgrade
Cronos upgraded to Hold on operational improvements at Canaccord » 07:45
05/11/22
05/11
07:45
05/11/22
07:45
CRON

Cronos Group

$3.19 /

+0.36 (+12.74%)

Canaccord analyst Matt…

Canaccord analyst Matt Bottomley upgraded Cronos Group to Hold from Sell with a price target of C$4.50, up from C$4.25. The company's Q1 results came in higher than expectations on continued gross margin expansion after finally inflecting into positive territory to end 2021, Bottomley tells investors in a research note. As of yesterday's closing price, Cronos Group's cash and short-term investments represented 93% of the company's C$1.4B market capitalization, says the analyst. Bottomley cites incremental operational improvements and a significant portion of the stock's current implied value supported by cash reserves for the upgrade.

ShowHide Related Items >><<
CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
05/09/22 Raymond James
Cronos Group price target raised to $6 from $5 at Raymond James
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

Upgrade
Cronos Group upgraded to Outperformer from Neutral at CIBC » 06:04
05/11/22
05/11
06:04
05/11/22
06:04
CRON

Cronos Group

$3.19 /

+0.36 (+12.74%)

CIBC analyst John Zamparo…

CIBC analyst John Zamparo upgraded Cronos Group to Outperformer from Neutral.

ShowHide Related Items >><<
CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
05/09/22 Raymond James
Cronos Group price target raised to $6 from $5 at Raymond James
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
03/22/22 Barclays
Cronos Group upgraded to Equal Weight from Underweight at Barclays
CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

Upgrade
Cronos Group upgraded to Hold from Sell at Canaccord » 06:04
05/11/22
05/11
06:04
05/11/22
06:04
CRON

Cronos Group

$3.19 /

+0.36 (+12.74%)

Canaccord analyst Matt…

Canaccord analyst Matt Bottomley upgraded Cronos Group to Hold from Sell with a C$4.50 price target.

ShowHide Related Items >><<
CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

05/09/22 Raymond James
Cronos Group price target raised to $6 from $5 at Raymond James
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
03/22/22 Barclays
Cronos Group upgraded to Equal Weight from Underweight at Barclays
03/21/22 Stifel
Stifel takes neutral overall view of Cronos' CEO transition
CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

On The Fly
What You Missed On Wall Street On Tuesday » 16:39
05/10/22
05/10
16:39
05/10/22
16:39
PFE

Pfizer

$49.48 /

+0.79 (+1.62%)

, BHVN

Biohaven Pharmaceutical

$140.00 /

+56.78 (+68.23%)

, PTON

Peloton

$12.91 /

-1.215 (-8.60%)

, GOOG

Alphabet

$2,292.38 /

+31.09 (+1.37%)

, GOOGL

Alphabet Class A

$2,287.83 /

+37.4 (+1.66%)

, MTCH

Match Group

$70.29 /

-0.44 (-0.62%)

, PLD

Prologis

$125.41 /

-6.84 (-5.17%)

, DRE

Duke Realty

$49.63 /

+1.94 (+4.07%)

, SOFI

SoFi Technologies

$5.24 /

-0.725 (-12.15%)

, UPST

Upstart

$33.63 /

-43.55 (-56.43%)

, MO

Altria Group

$51.59 /

-3.67 (-6.64%)

, PLTR

Palantir

$7.28 /

-0.18 (-2.41%)

, ALV

Autoliv

$71.25 /

+0.68 (+0.96%)

, TSLA

Tesla

$800.05 /

+12.745 (+1.62%)

, C

Citi

$48.75 /

-1.15 (-2.30%)

, NFLX

Netflix

$177.65 /

+4.655 (+2.69%)

, TEVA

Teva

$7.49 /

+0.06 (+0.81%)

, ABBV

AbbVie

$152.08 /

+1.155 (+0.77%)

, AAPL

Apple

$154.47 /

+2.27 (+1.49%)

, APPN

Appian

$59.62 /

+16.605 (+38.61%)

, AHCO

AdaptHealth

$14.84 /

+3.43 (+30.06%)

, PEGA

Pegasystems

$52.35 /

-13.58 (-20.60%)

, AUPH

Aurinia Pharmaceuticals

$11.27 /

+2.315 (+25.87%)

, CRON

Cronos Group

$3.19 /

+0.36 (+12.74%)

, UWMC

UWM Holdings

$3.60 /

+0.115 (+3.30%)

, DM

Desktop Metal

$1.32 /

-2.1 (-61.40%)

, EYE

National Vision

$24.92 /

-8.72 (-25.92%)

, BHC

Bausch Health

$9.40 /

-3.5101 (-27.19%)

, PLNT

Planet Fitness

$67.77 /

-1.15 (-1.67%)

, GDRX

GoodRx

$7.96 /

-2.795 (-26.00%)

, REYN

Reynolds Consumer Products

$29.30 /

+0.29 (+1.00%)

Get caught up quickly on…

ShowHide Related Items >><<
UWMC UWM Holdings
$3.60 /

+0.115 (+3.30%)

UPST Upstart
$33.63 /

-43.55 (-56.43%)

TSLA Tesla
$800.05 /

+12.745 (+1.62%)

TEVA Teva
$7.49 /

+0.06 (+0.81%)

SOFI SoFi Technologies
$5.24 /

-0.725 (-12.15%)

PTON Peloton
$12.91 /

-1.215 (-8.60%)

PLTR Palantir
$7.28 /

-0.18 (-2.41%)

PLNT Planet Fitness
$67.77 /

-1.15 (-1.67%)

PLD Prologis
$125.41 /

-6.84 (-5.17%)

PFE Pfizer
$49.48 /

+0.79 (+1.62%)

PEGA Pegasystems
$52.35 /

-13.58 (-20.60%)

NFLX Netflix
$177.65 /

+4.655 (+2.69%)

MTCH Match Group
$70.29 /

-0.44 (-0.62%)

MO Altria Group
$51.59 /

-3.67 (-6.64%)

GOOG Alphabet
$2,292.38 /

+31.09 (+1.37%)

GDRX GoodRx
$7.96 /

-2.795 (-26.00%)

EYE National Vision
$24.92 /

-8.72 (-25.92%)

DRE Duke Realty
$49.63 /

+1.94 (+4.07%)

DM Desktop Metal
$1.32 /

-2.1 (-61.40%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

C Citi
$48.75 /

-1.15 (-2.30%)

BHVN Biohaven Pharmaceutical
$140.00 /

+56.78 (+68.23%)

BHC Bausch Health
$9.40 /

-3.5101 (-27.19%)

AUPH Aurinia Pharmaceuticals
$11.27 /

+2.315 (+25.87%)

APPN Appian
$59.62 /

+16.605 (+38.61%)

ALV Autoliv
$71.25 /

+0.68 (+0.96%)

AHCO AdaptHealth
$14.84 /

+3.43 (+30.06%)

ABBV AbbVie
$152.08 /

+1.155 (+0.77%)

AAPL Apple
$154.47 /

+2.27 (+1.49%)

PFE Pfizer
$49.48 /

+0.79 (+1.62%)

05/11/22 Wedbush
Global Blood Therapeutics added to Best Ideas List at Wedbush
05/05/22 Stifel
Stifel keeps Buy rating on Arvinas, lowers price target to $82
05/04/22 Wells Fargo
Pfizer price target lowered to $55 from $60 at Wells Fargo
05/03/22 RBC Capital
Clinical hold being lifted a 'clear positive' for Sangamo, says RBC Capital
BHVN Biohaven Pharmaceutical
$140.00 /

+56.78 (+68.23%)

05/02/22 Piper Sandler
Piper sees 'outright misinformation' on Biohaven, says buy shares
04/22/22 Piper Sandler
Biohaven widening lead over AbbVie in migraine, says Piper Sandler
03/03/22 Mizuho
Biohaven Pharmaceutical price target raised to $154 from $144 at Mizuho
PTON Peloton
$12.91 /

-1.215 (-8.60%)

05/11/22 Needham
Peloton price target lowered to $25 from $50 at Needham
05/11/22 BMO Capital
Peloton price target lowered to $12 from $24 at BMO Capital
05/11/22 Deutsche Bank
Peloton price target lowered to $34 from $51 at Deutsche Bank
05/11/22 Baird
Peloton price target lowered to $25 from $46 at Baird
GOOG Alphabet
$2,292.38 /

+31.09 (+1.37%)

05/10/22 Piper Sandler
Match Group suit against Google not surprising, says Piper Sandler
05/03/22 Cowen
Enovix order 'perhaps' from Apple or Google, says Cowen
05/02/22 Rosenblatt
Apple price target lowered to $168 from $184 at Rosenblatt
04/27/22 Guggenheim
Alphabet price target lowered to $3,000 from $3,350 at Guggenheim
GOOGL Alphabet Class A
$2,287.83 /

+37.4 (+1.66%)

MTCH Match Group
$70.29 /

-0.44 (-0.62%)

05/09/22 Wells Fargo
Wells Fargo upgrades Match Group to Overweight, lowers price target to $115
05/09/22 Wells Fargo
Match Group upgraded to Overweight from Equal Weight at Wells Fargo
05/05/22 RBC Capital
Match Group price target lowered to $115 from $150 at RBC Capital
PLD Prologis
$125.41 /

-6.84 (-5.17%)

05/10/22 Truist
Prologis made 'compelling' bid for Duke Realty, says Truist
04/28/22 Wells Fargo
Prologis price target raised to $184 from $172 at Wells Fargo
04/25/22 Raymond James
Prologis price target raised to $190 from $180 at Raymond James
04/22/22 Deutsche Bank
Prologis price target raised to $184 from $179 at Deutsche Bank
DRE Duke Realty
$49.63 /

+1.94 (+4.07%)

03/15/22 Wells Fargo
Duke Realty price target lowered to $59 from $64 at Wells Fargo
01/18/22 Truist
Duke Realty downgraded to Hold from Buy at Truist
01/13/22 Mizuho
Duke Realty price target raised to $65 from $50 at Mizuho
SOFI SoFi Technologies
$5.24 /

-0.725 (-12.15%)

05/11/22 Credit Suisse
SoFi Technologies price target lowered to $9.50 from $15.50 at Credit Suisse
05/10/22 BofA
SoFi Technologies price target lowered to $7 from $12 at BofA
04/08/22 Citi
SoFi Technologies price target lowered to $17 from $20 at Citi
04/07/22 BofA
SoFi Technologies price target lowered to $12 from $14 at BofA
UPST Upstart
$33.63 /

-43.55 (-56.43%)

05/11/22 Atlantic Equities
Upstart downgraded on use of balance sheet at Atlantic Equities
05/11/22 Atlantic Equities
Upstart downgraded to Neutral from Overweight at Atlantic Equities
05/10/22 BofA
Upstart downgraded to Neutral from Buy at BofA
05/10/22 Goldman Sachs
Upstart downgraded to Neutral from Buy at Goldman Sachs
MO Altria Group
$51.59 /

-3.67 (-6.64%)

05/10/22 Bernstein
Altria Group downgraded to Market Perform from Outperform at Bernstein
05/09/22 Jefferies
PM buying Swedish Match would have negative read for Altria, says Jefferies
04/29/22 Deutsche Bank
Altria Group price target raised to $60 from $54 at Deutsche Bank
04/07/22 Cowen
Altria Group price target raised to $53 from $51 at Cowen
PLTR Palantir
$7.28 /

-0.18 (-2.41%)

05/10/22 Deutsche Bank
Palantir price target lowered to $11 from $15 at Deutsche Bank
05/10/22 Citi
Palantir price target lowered to $7 from $10 at Citi
05/09/22 RBC Capital
RBC downgrades Palantir to sell, halves target after 'disappointing' Q1
05/09/22 RBC Capital
Palantir downgraded to Underperform from Sector Perform at RBC Capital
ALV Autoliv
$71.25 /

+0.68 (+0.96%)

05/09/22 UBS
Autoliv upgraded to Buy on attractive entry point at UBS
05/09/22 UBS
Autoliv upgraded to Buy from Neutral at UBS
04/26/22 Deutsche Bank
Autoliv price target lowered to $86 from $96 at Deutsche Bank
04/25/22 RBC Capital
Autoliv price target lowered to $97 from $116 at RBC Capital
TSLA Tesla
$800.05 /

+12.745 (+1.62%)

05/10/22 Berenberg
Tesla initiated with a Hold at Berenberg
04/27/22 Wedbush
Twitter transaction 'was never ideal' for Tesla investors, says Wedbush
04/26/22 Wedbush
'Soap opera' now ends with Musk owning Twitter, says Wedbush
04/25/22 Gordon Haskett
Twitter bid more attractive after market selloff, says Gordon Haskett
C Citi
$48.75 /

-1.15 (-2.30%)

05/03/22 Oppenheimer
Citi price target lowered to $93 from $100 at Oppenheimer
04/06/22 Barclays
Citi price target lowered to $67 from $73 at Barclays
04/05/22 Piper Sandler
Citi price target lowered to $70 from $80 at Piper Sandler
03/28/22 Morgan Stanley
Morgan Stanley says 'war changes everything,' downgrades Citi to Underweight
NFLX Netflix
$177.65 /

+4.655 (+2.69%)

05/02/22 Morgan Stanley
New York Times' penetration opportunity remains compelling, says Morgan Stanley
04/21/22 Benchmark
Roku price target lowered to $240 from $305 at Benchmark
04/21/22 Citi
Netflix price target lowered to $295 from $450 at Citi
04/21/22 Edward Jones
Netflix downgraded to Hold from Buy at Edward Jones
TEVA Teva
$7.49 /

+0.06 (+0.81%)

05/04/22 Piper Sandler
Teva downgraded to Underweight from Neutral at Piper Sandler
04/05/22 Barclays
Teva upgraded to Overweight from Equal Weight at Barclays
03/25/22 Bernstein
Teva upgraded to Outperform from Market Perform at Bernstein
02/18/22 Barclays
Teva price target lowered to $11 from $13 at Barclays
ABBV AbbVie
$152.08 /

+1.155 (+0.77%)

05/06/22 Daiwa
AbbVie downgraded to Neutral from Outperform at Daiwa
05/03/22 Morgan Stanley
Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure
05/02/22 Morgan Stanley
AbbVie's recent weakness a buying opportunity, says Morgan Stanley
05/02/22 Wells Fargo
AbbVie price target raised to $200 from $165 at Wells Fargo
AAPL Apple
$154.47 /

+2.27 (+1.49%)

05/11/22 JMP Securities
Jamf Holding price target lowered to $39 from $59 at JMP Securities
05/04/22 Benchmark
Cirrus Logic price target lowered to $95 from $100 at Benchmark
05/04/22 Benchmark
Skyworks price target lowered to $155 from $190 at Benchmark
05/04/22 KeyBanc
Cirrus Logic price target lowered to $105 from $120 at KeyBanc
APPN Appian
$59.62 /

+16.605 (+38.61%)

05/11/22 Truist
Truist cuts Pegasystems to Hold after ruling awarded $2B in damages to Appian
04/27/22 Goldman Sachs
Appian initiated with a Buy at Goldman Sachs
04/19/22 Barclays
Appian price target lowered to $42 from $47 at Barclays
02/18/22 Truist
Appian price target lowered to $65 from $100 at Truist
AHCO AdaptHealth
$14.84 /

+3.43 (+30.06%)

05/11/22 Deutsche Bank
AdaptHealth price target lowered to $22 from $28 at Deutsche Bank
03/08/22 RBC Capital
AdaptHealth price target lowered to $26 from $31 at RBC Capital
02/25/22 Canaccord
AdaptHealth price target lowered to $29 from $44 at Canaccord
02/25/22 Truist
AdaptHealth price target lowered to $20 from $30 at Truist
PEGA Pegasystems
$52.35 /

-13.58 (-20.60%)

05/11/22 Truist
Pegasystems downgraded to Hold from Buy at Truist
05/04/22 Goldman Sachs
Pegasystems initiated with a Neutral at Goldman Sachs
04/29/22 JMP Securities
Pegasystems price target lowered to $100 from $155 at JMP Securities
AUPH Aurinia Pharmaceuticals
$11.27 /

+2.315 (+25.87%)

05/05/22 Cantor Fitzgerald
Aurinia Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
05/04/22 H.C. Wainwright
Aurinia Pharmaceuticals price target lowered to $30 from $33 at H.C. Wainwright
04/28/22 RBC Capital
Aurinia Pharmaceuticals price target lowered to $22 from $27 at RBC Capital
03/01/22 RBC Capital
Aurinia Pharmaceuticals price target lowered to $27 from $31 at RBC Capital
CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
05/09/22 Raymond James
Cronos Group price target raised to $6 from $5 at Raymond James
UWMC UWM Holdings
$3.60 /

+0.115 (+3.30%)

04/20/22 BTIG
UWM Holdings initiated with a Neutral at BTIG
03/03/22 Barclays
UWM Holdings price target lowered to $5 from $7 at Barclays
02/23/22 UBS
UWM Holdings downgraded to Neutral from Buy at UBS
02/23/22 UBS
UWM Holdings downgraded to Neutral from Buy at UBS
DM Desktop Metal
$1.32 /

-2.1 (-61.40%)

03/16/22 Stifel
Desktop Metal price target lowered to $6 from $11 at Stifel
01/10/22 Lake Street
Desktop Metal upgraded to Hold from Sell at Lake Street
01/10/22 Lake Street
Desktop Metal upgraded to Buy from Hold at Lake Street
11/17/21 Credit Suisse
Desktop Metal resumed with Neutral at Credit Suisse
EYE National Vision
$24.92 /

-8.72 (-25.92%)

04/01/22 Barclays
National Vision price target raised to $52 from $43 at Barclays
03/01/22 Citi
National Vision price target lowered to $55 from $58 at Citi
01/05/22 Wells Fargo
National Vision price target lowered to $60 from $65 at Wells Fargo
11/15/21 Goldman Sachs
National Vision downgraded to Neutral from Buy at Goldman Sachs
BHC Bausch Health
$9.40 /

-3.5101 (-27.19%)

05/11/22 Cowen
Cowen starts Bausch + Lomb at Outperform with $35 price target
05/11/22 BofA
Bausch Health price target lowered to $12 from $25 at BofA
02/01/22 RBC Capital
Bausch Health price target lowered to $34 from $40 at RBC Capital
11/03/21 JPMorgan
Bausch Health earnings selloff a buying opportunity, says JPMorgan
PLNT Planet Fitness
$67.77 /

-1.15 (-1.67%)

05/11/22 JPMorgan
Planet Fitness upgraded to Overweight on usage trends at JPMorgan
05/11/22 Baird
Planet Fitness price target lowered to $92 from $108 at Baird
05/11/22 Piper Sandler
Planet Fitness price target lowered to $72 from $87 at Piper Sandler
05/11/22 JPMorgan
Planet Fitness upgraded to Overweight from Neutral at JPMorgan
GDRX GoodRx
$7.96 /

-2.795 (-26.00%)

05/11/22 Deutsche Bank
GoodRx price target lowered to $10 from $20 at Deutsche Bank
05/11/22 Credit Suisse
GoodRx price target lowered to $10 from $22 at Credit Suisse
05/10/22 Raymond James
GoodRx downgraded to Market Perform from Outperform at Raymond James
05/10/22 RBC Capital
RBC Capital cuts GoodRx to Sector Perform on reduced visibility, pulled guidance
REYN Reynolds Consumer Products
$29.30 /

+0.29 (+1.00%)

04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold at Stifel on higher input costs
04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold from Buy at Stifel
03/30/22 JPMorgan
Reynolds Consumer Products price target lowered to $33 from $34 at JPMorgan
03/29/22 Goldman Sachs
Reynolds Consumer Products downgraded to Sell from Buy at Goldman Sachs
UWMC UWM Holdings
$3.60 /

+0.115 (+3.30%)

UPST Upstart
$33.63 /

-43.55 (-56.43%)

TSLA Tesla
$800.05 /

+12.745 (+1.62%)

TEVA Teva
$7.49 /

+0.06 (+0.81%)

SOFI SoFi Technologies
$5.24 /

-0.725 (-12.15%)

REYN Reynolds Consumer Products
$29.30 /

+0.29 (+1.00%)

PTON Peloton
$12.91 /

-1.215 (-8.60%)

PLTR Palantir
$7.28 /

-0.18 (-2.41%)

PLNT Planet Fitness
$67.77 /

-1.15 (-1.67%)

PLD Prologis
$125.41 /

-6.84 (-5.17%)

PFE Pfizer
$49.48 /

+0.79 (+1.62%)

PEGA Pegasystems
$52.35 /

-13.58 (-20.60%)

NFLX Netflix
$177.65 /

+4.655 (+2.69%)

MTCH Match Group
$70.29 /

-0.44 (-0.62%)

MO Altria Group
$51.59 /

-3.67 (-6.64%)

GOOG Alphabet
$2,292.38 /

+31.09 (+1.37%)

GDRX GoodRx
$7.96 /

-2.795 (-26.00%)

EYE National Vision
$24.92 /

-8.72 (-25.92%)

DRE Duke Realty
$49.63 /

+1.94 (+4.07%)

DM Desktop Metal
$1.32 /

-2.1 (-61.40%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

C Citi
$48.75 /

-1.15 (-2.30%)

BHVN Biohaven Pharmaceutical
$140.00 /

+56.78 (+68.23%)

BHC Bausch Health
$9.40 /

-3.5101 (-27.19%)

AUPH Aurinia Pharmaceuticals
$11.27 /

+2.315 (+25.87%)

APPN Appian
$59.62 /

+16.605 (+38.61%)

ALV Autoliv
$71.25 /

+0.68 (+0.96%)

AHCO AdaptHealth
$14.84 /

+3.43 (+30.06%)

ABBV AbbVie
$152.08 /

+1.155 (+0.77%)

AAPL Apple
$154.47 /

+2.27 (+1.49%)

  • 19
    Nov
  • 16
    Nov
  • 16
    Nov
  • 16
    Jun
TSLA Tesla
$800.05 /

+12.745 (+1.62%)

TEVA Teva
$7.49 /

+0.06 (+0.81%)

SOFI SoFi Technologies
$5.24 /

-0.725 (-12.15%)

PTON Peloton
$12.91 /

-1.215 (-8.60%)

PLTR Palantir
$7.28 /

-0.18 (-2.41%)

PLNT Planet Fitness
$67.77 /

-1.15 (-1.67%)

PLD Prologis
$125.41 /

-6.84 (-5.17%)

PFE Pfizer
$49.48 /

+0.79 (+1.62%)

NFLX Netflix
$177.65 /

+4.655 (+2.69%)

MO Altria Group
$51.59 /

-3.67 (-6.64%)

GOOG Alphabet
$2,292.38 /

+31.09 (+1.37%)

DRE Duke Realty
$49.63 /

+1.94 (+4.07%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

C Citi
$48.75 /

-1.15 (-2.30%)

BHVN Biohaven Pharmaceutical
$140.00 /

+56.78 (+68.23%)

BHC Bausch Health
$9.40 /

-3.5101 (-27.19%)

AUPH Aurinia Pharmaceuticals
$11.27 /

+2.315 (+25.87%)

ABBV AbbVie
$152.08 /

+1.155 (+0.77%)

AAPL Apple
$154.47 /

+2.27 (+1.49%)

UWMC UWM Holdings
$3.60 /

+0.115 (+3.30%)

UPST Upstart
$33.63 /

-43.55 (-56.43%)

TEVA Teva
$7.49 /

+0.06 (+0.81%)

SOFI SoFi Technologies
$5.24 /

-0.725 (-12.15%)

REYN Reynolds Consumer Products
$29.30 /

+0.29 (+1.00%)

PTON Peloton
$12.91 /

-1.215 (-8.60%)

PLNT Planet Fitness
$67.77 /

-1.15 (-1.67%)

PFE Pfizer
$49.48 /

+0.79 (+1.62%)

PEGA Pegasystems
$52.35 /

-13.58 (-20.60%)

NFLX Netflix
$177.65 /

+4.655 (+2.69%)

MTCH Match Group
$70.29 /

-0.44 (-0.62%)

MO Altria Group
$51.59 /

-3.67 (-6.64%)

GOOG Alphabet
$2,292.38 /

+31.09 (+1.37%)

DM Desktop Metal
$1.32 /

-2.1 (-61.40%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

C Citi
$48.75 /

-1.15 (-2.30%)

BHVN Biohaven Pharmaceutical
$140.00 /

+56.78 (+68.23%)

BHC Bausch Health
$9.40 /

-3.5101 (-27.19%)

AUPH Aurinia Pharmaceuticals
$11.27 /

+2.315 (+25.87%)

APPN Appian
$59.62 /

+16.605 (+38.61%)

ALV Autoliv
$71.25 /

+0.68 (+0.96%)

ABBV AbbVie
$152.08 /

+1.155 (+0.77%)

AAPL Apple
$154.47 /

+2.27 (+1.49%)

UWMC UWM Holdings
$3.60 /

+0.115 (+3.30%)

UPST Upstart
$33.63 /

-43.55 (-56.43%)

TSLA Tesla
$800.05 /

+12.745 (+1.62%)

TEVA Teva
$7.49 /

+0.06 (+0.81%)

SOFI SoFi Technologies
$5.24 /

-0.725 (-12.15%)

PTON Peloton
$12.91 /

-1.215 (-8.60%)

PLTR Palantir
$7.28 /

-0.18 (-2.41%)

PLD Prologis
$125.41 /

-6.84 (-5.17%)

PFE Pfizer
$49.48 /

+0.79 (+1.62%)

NFLX Netflix
$177.65 /

+4.655 (+2.69%)

MTCH Match Group
$70.29 /

-0.44 (-0.62%)

MO Altria Group
$51.59 /

-3.67 (-6.64%)

GOOGL Alphabet Class A
$2,287.83 /

+37.4 (+1.66%)

GOOG Alphabet
$2,292.38 /

+31.09 (+1.37%)

GDRX GoodRx
$7.96 /

-2.795 (-26.00%)

DRE Duke Realty
$49.63 /

+1.94 (+4.07%)

DM Desktop Metal
$1.32 /

-2.1 (-61.40%)

CRON Cronos Group
$3.19 /

+0.36 (+12.74%)

C Citi
$48.75 /

-1.15 (-2.30%)

BHC Bausch Health
$9.40 /

-3.5101 (-27.19%)

AUPH Aurinia Pharmaceuticals
$11.27 /

+2.315 (+25.87%)

APPN Appian
$59.62 /

+16.605 (+38.61%)

ABBV AbbVie
$152.08 /

+1.155 (+0.77%)

AAPL Apple
$154.47 /

+2.27 (+1.49%)

On The Fly
What You Missed On Wall Street This Morning » 12:01
05/10/22
05/10
12:01
05/10/22
12:01
BHVN

Biohaven Pharmaceutical

$141.55 /

+58.33 (+70.09%)

, PFE

Pfizer

$49.06 /

+0.37 (+0.76%)

, PTON

Peloton

$12.24 /

-1.885 (-13.35%)

, UPST

Upstart

$30.97 /

-46.21 (-59.87%)

, MTCH

Match Group

$68.96 /

-1.77 (-2.50%)

, GOOG

Alphabet

$2,295.72 /

+34.43 (+1.52%)

, GOOGL

Alphabet Class A

$2,286.31 /

+35.88 (+1.59%)

, PLD

Prologis

$125.56 /

-6.69 (-5.06%)

, DRE

Duke Realty

$51.87 /

+4.18 (+8.76%)

, MO

Altria Group

$50.90 /

-4.36 (-7.89%)

, PLTR

Palantir

$7.05 /

-0.41 (-5.50%)

, ALV

Autoliv

$70.78 /

+0.21 (+0.30%)

, TSLA

Tesla

$785.81 /

-1.49 (-0.19%)

, EBS

Emergent BioSolutions

$30.43 /

-0.16 (-0.52%)

, C

Citi

$48.39 /

-1.51 (-3.03%)

, NFLX

Netflix

$174.36 /

+1.365 (+0.79%)

, FB

Meta Platforms

$196.67 /

+0.41 (+0.21%)

, APPN

Appian

$54.56 /

+11.55 (+26.85%)

, PEGA

Pegasystems

$44.21 /

-21.72 (-32.94%)

, AHCO

AdaptHealth

$13.59 /

+2.18 (+19.11%)

, AUPH

Aurinia Pharmaceuticals

$10.78 /

+1.83 (+20.45%)

, CRON

Cronos Group

$3.11 /

+0.285 (+10.09%)

, UWMC

UWM Holdings

$3.54 /

+0.06 (+1.72%)

, DM

Desktop Metal

$1.96 /

-1.46 (-42.69%)

, EYE

National Vision

$25.19 /

-8.45 (-25.12%)

, PLNT

Planet Fitness

$69.77 /

+0.85 (+1.23%)

, GDRX

GoodRx

$7.79 /

-2.96 (-27.53%)

, BHC

Bausch Health

$9.80 /

-3.11 (-24.09%)

, REYN

Reynolds Consumer Products

$30.35 /

+1.34 (+4.62%)

, FOX

Fox Corp.

$30.00 /

-0.56 (-1.83%)

, FOXA

Fox Corp.

$32.59 /

-0.62 (-1.87%)

Get caught up quickly on…

ShowHide Related Items >><<
UWMC UWM Holdings
$3.54 /

+0.06 (+1.72%)

UPST Upstart
$30.97 /

-46.21 (-59.87%)

TSLA Tesla
$785.81 /

-1.49 (-0.19%)

PTON Peloton
$12.24 /

-1.885 (-13.35%)

PLTR Palantir
$7.05 /

-0.41 (-5.50%)

PLNT Planet Fitness
$69.77 /

+0.85 (+1.23%)

PLD Prologis
$125.56 /

-6.69 (-5.06%)

PFE Pfizer
$49.06 /

+0.37 (+0.76%)

PEGA Pegasystems
$44.21 /

-21.72 (-32.94%)

NFLX Netflix
$174.36 /

+1.365 (+0.79%)

MTCH Match Group
$68.96 /

-1.77 (-2.50%)

MO Altria Group
$50.90 /

-4.36 (-7.89%)

GOOG Alphabet
$2,295.72 /

+34.43 (+1.52%)

GDRX GoodRx
$7.79 /

-2.96 (-27.53%)

FOXA Fox Corp.
$32.59 /

-0.62 (-1.87%)

FOX Fox Corp.
$30.00 /

-0.56 (-1.83%)

FB Meta Platforms
$196.67 /

+0.41 (+0.21%)

EYE National Vision
$25.19 /

-8.45 (-25.12%)

EBS Emergent BioSolutions
$30.43 /

-0.16 (-0.52%)

DRE Duke Realty
$51.87 /

+4.18 (+8.76%)

DM Desktop Metal
$1.96 /

-1.46 (-42.69%)

CRON Cronos Group
$3.11 /

+0.285 (+10.09%)

C Citi
$48.39 /

-1.51 (-3.03%)

BHVN Biohaven Pharmaceutical
$141.55 /

+58.33 (+70.09%)

BHC Bausch Health
$9.80 /

-3.11 (-24.09%)

AUPH Aurinia Pharmaceuticals
$10.78 /

+1.83 (+20.45%)

APPN Appian
$54.56 /

+11.55 (+26.85%)

ALV Autoliv
$70.78 /

+0.21 (+0.30%)

AHCO AdaptHealth
$13.59 /

+2.18 (+19.11%)

BHVN Biohaven Pharmaceutical
$141.55 /

+58.33 (+70.09%)

05/02/22 Piper Sandler
Piper sees 'outright misinformation' on Biohaven, says buy shares
04/22/22 Piper Sandler
Biohaven widening lead over AbbVie in migraine, says Piper Sandler
03/03/22 Mizuho
Biohaven Pharmaceutical price target raised to $154 from $144 at Mizuho
02/25/22 Piper Sandler
Biohaven continues execution story with two deals, says Piper Sandler
PFE Pfizer
$49.06 /

+0.37 (+0.76%)

05/05/22 Stifel
Stifel keeps Buy rating on Arvinas, lowers price target to $82
05/04/22 Wells Fargo
Pfizer price target lowered to $55 from $60 at Wells Fargo
05/03/22 RBC Capital
Clinical hold being lifted a 'clear positive' for Sangamo, says RBC Capital
04/20/22 Piper Sandler
Piper says 'do not be fooled,' Arcturus Phase 3 shows strong vaccine efficacy
PTON Peloton
$12.24 /

-1.885 (-13.35%)

04/19/22 Citi
Peloton assumed with Buy from Neutral at Citi
04/08/22 Morgan Stanley
Peloton may top 3M Connected Fitness subscribers in Q3, says Morgan Stanley
03/31/22 Evercore ISI
Peloton shares may stay range-bound in near-to-mid-term, says Evercore ISI
03/14/22 Bernstein
Peloton initiated with an Outperform at Bernstein
UPST Upstart
$30.97 /

-46.21 (-59.87%)

05/10/22 Goldman Sachs
Upstart downgraded to Neutral from Buy at Goldman Sachs
05/10/22 Wedbush
Upstart price target lowered to $35 from $70 at Wedbush
05/10/22 Stephens
Upstart downgraded to Underweight from Equal Weight at Stephens
05/10/22 Stephens
Affirm downgraded to Underweight at Stephens after Upstart earnings
MTCH Match Group
$68.96 /

-1.77 (-2.50%)

05/10/22 Piper Sandler
Match Group suit against Google not surprising, says Piper Sandler
05/09/22 Wells Fargo
Wells Fargo upgrades Match Group to Overweight, lowers price target to $115
05/09/22 Wells Fargo
Match Group upgraded to Overweight from Equal Weight at Wells Fargo
05/05/22 RBC Capital
Match Group price target lowered to $115 from $150 at RBC Capital
GOOG Alphabet
$2,295.72 /

+34.43 (+1.52%)

05/03/22 Cowen
Enovix order 'perhaps' from Apple or Google, says Cowen
05/02/22 Rosenblatt
Apple price target lowered to $168 from $184 at Rosenblatt
04/27/22 Guggenheim
Alphabet price target lowered to $3,000 from $3,350 at Guggenheim
GOOGL Alphabet Class A
$2,286.31 /

+35.88 (+1.59%)

PLD Prologis
$125.56 /

-6.69 (-5.06%)

04/28/22 Wells Fargo
Prologis price target raised to $184 from $172 at Wells Fargo
04/25/22 Raymond James
Prologis price target raised to $190 from $180 at Raymond James
04/22/22 Deutsche Bank
Prologis price target raised to $184 from $179 at Deutsche Bank
04/21/22 Barclays
Prologis price target raised to $190 from $171 at Barclays
DRE Duke Realty
$51.87 /

+4.18 (+8.76%)

03/15/22 Wells Fargo
Duke Realty price target lowered to $59 from $64 at Wells Fargo
01/18/22 Truist
Duke Realty downgraded to Hold from Buy at Truist
01/13/22 Mizuho
Duke Realty price target raised to $65 from $50 at Mizuho
01/07/22 BMO Capital
Duke Realty downgraded to Market Perform from Outperform at BMO Capital
MO Altria Group
$50.90 /

-4.36 (-7.89%)

05/10/22 Bernstein
Altria Group downgraded to Market Perform from Outperform at Bernstein
05/09/22 Jefferies
PM buying Swedish Match would have negative read for Altria, says Jefferies
04/29/22 Deutsche Bank
Altria Group price target raised to $60 from $54 at Deutsche Bank
04/07/22 Cowen
Altria Group price target raised to $53 from $51 at Cowen
PLTR Palantir
$7.05 /

-0.41 (-5.50%)

05/10/22 Deutsche Bank
Palantir price target lowered to $11 from $15 at Deutsche Bank
05/10/22 Citi
Palantir price target lowered to $7 from $10 at Citi
05/09/22 RBC Capital
RBC downgrades Palantir to sell, halves target after 'disappointing' Q1
05/09/22 RBC Capital
Palantir downgraded to Underperform from Sector Perform at RBC Capital
ALV Autoliv
$70.78 /

+0.21 (+0.30%)

05/09/22 UBS
Autoliv upgraded to Buy on attractive entry point at UBS
05/09/22 UBS
Autoliv upgraded to Buy from Neutral at UBS
04/26/22 Deutsche Bank
Autoliv price target lowered to $86 from $96 at Deutsche Bank
04/25/22 RBC Capital
Autoliv price target lowered to $97 from $116 at RBC Capital
TSLA Tesla
$785.81 /

-1.49 (-0.19%)

05/10/22 Berenberg
Tesla initiated with a Hold at Berenberg
04/27/22 Wedbush
Twitter transaction 'was never ideal' for Tesla investors, says Wedbush
04/26/22 Wedbush
'Soap opera' now ends with Musk owning Twitter, says Wedbush
04/25/22 Gordon Haskett
Twitter bid more attractive after market selloff, says Gordon Haskett
EBS Emergent BioSolutions
$30.43 /

-0.16 (-0.52%)

05/04/22 Wells Fargo
Emergent BioSolutions price target lowered to $38 from $46 at Wells Fargo
04/29/22 Cantor Fitzgerald
Emergent BioSolutions downgraded to Neutral from Overweight at Cantor Fitzgerald
04/29/22 Cowen
Emergent BioSolutions price target lowered to $30 from $40 at Cowen
04/29/22 Chardan
Emergent BioSolutions price target lowered to $65 from $75 at Chardan
C Citi
$48.39 /

-1.51 (-3.03%)

05/03/22 Oppenheimer
Citi price target lowered to $93 from $100 at Oppenheimer
04/06/22 Barclays
Citi price target lowered to $67 from $73 at Barclays
04/05/22 Piper Sandler
Citi price target lowered to $70 from $80 at Piper Sandler
03/28/22 Morgan Stanley
Morgan Stanley says 'war changes everything,' downgrades Citi to Underweight
NFLX Netflix
$174.36 /

+1.365 (+0.79%)

05/02/22 Morgan Stanley
New York Times' penetration opportunity remains compelling, says Morgan Stanley
04/21/22 Benchmark
Roku price target lowered to $240 from $305 at Benchmark
04/21/22 Citi
Netflix price target lowered to $295 from $450 at Citi
04/21/22 Edward Jones
Netflix downgraded to Hold from Buy at Edward Jones
FB Meta Platforms
$196.67 /

+0.41 (+0.21%)

04/28/22 MKM Partners
Meta Platforms price target lowered to $295 from $315 at MKM Partners
04/28/22 Evercore ISI
Meta Platforms price target lowered to $325 from $350 at Evercore ISI
04/28/22 Oppenheimer
Oppenheimer maintains Outperform, $305 target on Meta Platforms after Q1 results
04/28/22 Credit Suisse
Credit Suisse raises Meta Platforms price target to $273 after quarterly results
APPN Appian
$54.56 /

+11.55 (+26.85%)

04/27/22 Goldman Sachs
Appian initiated with a Buy at Goldman Sachs
04/19/22 Barclays
Appian price target lowered to $42 from $47 at Barclays
02/18/22 Truist
Appian price target lowered to $65 from $100 at Truist
01/12/22 Barclays
Appian price target lowered to $47 from $90 at Barclays
PEGA Pegasystems
$44.21 /

-21.72 (-32.94%)

05/04/22 Goldman Sachs
Pegasystems initiated with a Neutral at Goldman Sachs
04/29/22 JMP Securities
Pegasystems price target lowered to $100 from $155 at JMP Securities
04/19/22 Barclays
Pegasystems price target lowered to $80 from $110 at Barclays
03/08/22 Truist
Pegasystems initiated with a Buy at Truist
AHCO AdaptHealth
$13.59 /

+2.18 (+19.11%)

03/08/22 RBC Capital
AdaptHealth price target lowered to $26 from $31 at RBC Capital
02/25/22 Canaccord
AdaptHealth price target lowered to $29 from $44 at Canaccord
02/25/22 Truist
AdaptHealth price target lowered to $20 from $30 at Truist
02/25/22 Deutsche Bank
AdaptHealth price target lowered to $28 from $34 at Deutsche Bank
AUPH Aurinia Pharmaceuticals
$10.78 /

+1.83 (+20.45%)

05/05/22 Cantor Fitzgerald
Aurinia Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald
05/04/22 H.C. Wainwright
Aurinia Pharmaceuticals price target lowered to $30 from $33 at H.C. Wainwright
04/28/22 RBC Capital
Aurinia Pharmaceuticals price target lowered to $22 from $27 at RBC Capital
03/01/22 RBC Capital
Aurinia Pharmaceuticals price target lowered to $27 from $31 at RBC Capital
CRON Cronos Group
$3.11 /

+0.285 (+10.09%)

05/09/22 Raymond James
Cronos Group price target raised to $6 from $5 at Raymond James
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
03/22/22 Barclays
Cronos Group upgraded to Equal Weight from Underweight at Barclays
03/21/22 Stifel
Stifel takes neutral overall view of Cronos' CEO transition
UWMC UWM Holdings
$3.54 /

+0.06 (+1.72%)

04/20/22 BTIG
UWM Holdings initiated with a Neutral at BTIG
03/03/22 Barclays
UWM Holdings price target lowered to $5 from $7 at Barclays
02/23/22 UBS
UWM Holdings downgraded to Neutral from Buy at UBS
02/23/22 UBS
UWM Holdings downgraded to Neutral from Buy at UBS
DM Desktop Metal
$1.96 /

-1.46 (-42.69%)

03/16/22 Stifel
Desktop Metal price target lowered to $6 from $11 at Stifel
01/10/22 Lake Street
Desktop Metal upgraded to Hold from Sell at Lake Street
01/10/22 Lake Street
Desktop Metal upgraded to Buy from Hold at Lake Street
11/17/21 Credit Suisse
Desktop Metal resumed with Neutral at Credit Suisse
EYE National Vision
$25.19 /

-8.45 (-25.12%)

04/01/22 Barclays
National Vision price target raised to $52 from $43 at Barclays
03/01/22 Citi
National Vision price target lowered to $55 from $58 at Citi
01/05/22 Wells Fargo
National Vision price target lowered to $60 from $65 at Wells Fargo
11/15/21 Goldman Sachs
National Vision downgraded to Neutral from Buy at Goldman Sachs
PLNT Planet Fitness
$69.77 /

+0.85 (+1.23%)

05/09/22 Evercore ISI
Planet Fitness added to 'Tactical Outperform' list at Evercore ISI
04/13/22 Cowen
Planet Fitness attractive with near-term catalysts, says Cowen
03/14/22 Evercore ISI
Evercore ISI starts Planet Fitness at Outperform with $130 price target
03/14/22 Evercore ISI
Planet Fitness initiated with an Outperform at Evercore ISI
GDRX GoodRx
$7.79 /

-2.96 (-27.53%)

05/10/22 Raymond James
GoodRx downgraded to Market Perform from Outperform at Raymond James
05/10/22 RBC Capital
RBC Capital cuts GoodRx to Sector Perform on reduced visibility, pulled guidance
05/10/22 Barclays
GoodRx price target lowered to $15 from $28 at Barclays
05/10/22 SVB Leerink
GoodRx downgraded to Market Perform from Outperform at SVB Leerink
BHC Bausch Health
$9.80 /

-3.11 (-24.09%)

02/01/22 RBC Capital
Bausch Health price target lowered to $34 from $40 at RBC Capital
11/03/21 JPMorgan
Bausch Health earnings selloff a buying opportunity, says JPMorgan
09/21/21 JPMorgan
Bausch has 50% upside based on sum-of-the-parts, says JPMorgan
08/04/21 JPMorgan
Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
REYN Reynolds Consumer Products
$30.35 /

+1.34 (+4.62%)

04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold at Stifel on higher input costs
04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold from Buy at Stifel
03/30/22 JPMorgan
Reynolds Consumer Products price target lowered to $33 from $34 at JPMorgan
03/29/22 Goldman Sachs
Reynolds Consumer Products downgraded to Sell from Buy at Goldman Sachs
FOX Fox Corp.
$30.00 /

-0.56 (-1.83%)

04/19/22 Rosenblatt
Fox Corp. initiated with a Neutral at Rosenblatt
12/14/21 Macquarie
Fox Corp. price target lowered to $37 from $40 at Macquarie
08/05/21 Guggenheim
Guggenheim upgrades Fox Corp. to Buy, maintains $41 price target
FOXA Fox Corp.
$32.59 /

-0.62 (-1.87%)

04/12/22 Vertical Group
Fox Corp. upgraded to Positive from Mixed at Vertical Group
02/11/22 Deutsche Bank
Fox Corp. price target raised to $48 from $47 at Deutsche Bank
01/24/22 UBS
Fox Corp. upgraded to Buy from Neutral at UBS
UWMC UWM Holdings
$3.54 /

+0.06 (+1.72%)

UPST Upstart
$30.97 /

-46.21 (-59.87%)

TSLA Tesla
$785.81 /

-1.49 (-0.19%)

REYN Reynolds Consumer Products
$30.35 /

+1.34 (+4.62%)

PTON Peloton
$12.24 /

-1.885 (-13.35%)

PLTR Palantir
$7.05 /

-0.41 (-5.50%)

PLNT Planet Fitness
$69.77 /

+0.85 (+1.23%)

PLD Prologis
$125.56 /

-6.69 (-5.06%)

PFE Pfizer
$49.06 /

+0.37 (+0.76%)

PEGA Pegasystems
$44.21 /

-21.72 (-32.94%)

NFLX Netflix
$174.36 /

+1.365 (+0.79%)

MTCH Match Group
$68.96 /

-1.77 (-2.50%)

MO Altria Group
$50.90 /

-4.36 (-7.89%)

GOOG Alphabet
$2,295.72 /

+34.43 (+1.52%)

GDRX GoodRx
$7.79 /

-2.96 (-27.53%)

FOX Fox Corp.
$30.00 /

-0.56 (-1.83%)

FB Meta Platforms
$196.67 /

+0.41 (+0.21%)

EYE National Vision
$25.19 /

-8.45 (-25.12%)

EBS Emergent BioSolutions
$30.43 /

-0.16 (-0.52%)

DRE Duke Realty
$51.87 /

+4.18 (+8.76%)

DM Desktop Metal
$1.96 /

-1.46 (-42.69%)

CRON Cronos Group
$3.11 /

+0.285 (+10.09%)

C Citi
$48.39 /

-1.51 (-3.03%)

BHVN Biohaven Pharmaceutical
$141.55 /

+58.33 (+70.09%)

BHC Bausch Health
$9.80 /

-3.11 (-24.09%)

AUPH Aurinia Pharmaceuticals
$10.78 /

+1.83 (+20.45%)

APPN Appian
$54.56 /

+11.55 (+26.85%)

ALV Autoliv
$70.78 /

+0.21 (+0.30%)

AHCO AdaptHealth
$13.59 /

+2.18 (+19.11%)

  • 19
    Nov
  • 16
    Nov
  • 16
    Nov
  • 16
    Jun
TSLA Tesla
$785.81 /

-1.49 (-0.19%)

PTON Peloton
$12.24 /

-1.885 (-13.35%)

PLTR Palantir
$7.05 /

-0.41 (-5.50%)

PLNT Planet Fitness
$69.77 /

+0.85 (+1.23%)

PLD Prologis
$125.56 /

-6.69 (-5.06%)

PFE Pfizer
$49.06 /

+0.37 (+0.76%)

NFLX Netflix
$174.36 /

+1.365 (+0.79%)

MO Altria Group
$50.90 /

-4.36 (-7.89%)

GOOG Alphabet
$2,295.72 /

+34.43 (+1.52%)

FOXA Fox Corp.
$32.59 /

-0.62 (-1.87%)

FOX Fox Corp.
$30.00 /

-0.56 (-1.83%)

FB Meta Platforms
$196.67 /

+0.41 (+0.21%)

EBS Emergent BioSolutions
$30.43 /

-0.16 (-0.52%)

DRE Duke Realty
$51.87 /

+4.18 (+8.76%)

CRON Cronos Group
$3.11 /

+0.285 (+10.09%)

C Citi
$48.39 /

-1.51 (-3.03%)

BHVN Biohaven Pharmaceutical
$141.55 /

+58.33 (+70.09%)

BHC Bausch Health
$9.80 /

-3.11 (-24.09%)

AUPH Aurinia Pharmaceuticals
$10.78 /

+1.83 (+20.45%)

UWMC UWM Holdings
$3.54 /

+0.06 (+1.72%)

UPST Upstart
$30.97 /

-46.21 (-59.87%)

TSLA Tesla
$785.81 /

-1.49 (-0.19%)

REYN Reynolds Consumer Products
$30.35 /

+1.34 (+4.62%)

PTON Peloton
$12.24 /

-1.885 (-13.35%)

PLTR Palantir
$7.05 /

-0.41 (-5.50%)

PLNT Planet Fitness
$69.77 /

+0.85 (+1.23%)

PFE Pfizer
$49.06 /

+0.37 (+0.76%)

PEGA Pegasystems
$44.21 /

-21.72 (-32.94%)

NFLX Netflix
$174.36 /

+1.365 (+0.79%)

MTCH Match Group
$68.96 /

-1.77 (-2.50%)

MO Altria Group
$50.90 /

-4.36 (-7.89%)

GOOG Alphabet
$2,295.72 /

+34.43 (+1.52%)

FOX Fox Corp.
$30.00 /

-0.56 (-1.83%)

FB Meta Platforms
$196.67 /

+0.41 (+0.21%)

DM Desktop Metal
$1.96 /

-1.46 (-42.69%)

CRON Cronos Group
$3.11 /

+0.285 (+10.09%)

C Citi
$48.39 /

-1.51 (-3.03%)

BHVN Biohaven Pharmaceutical
$141.55 /

+58.33 (+70.09%)

BHC Bausch Health
$9.80 /

-3.11 (-24.09%)

AUPH Aurinia Pharmaceuticals
$10.78 /

+1.83 (+20.45%)

APPN Appian
$54.56 /

+11.55 (+26.85%)

ALV Autoliv
$70.78 /

+0.21 (+0.30%)

UWMC UWM Holdings
$3.54 /

+0.06 (+1.72%)

UPST Upstart
$30.97 /

-46.21 (-59.87%)

TSLA Tesla
$785.81 /

-1.49 (-0.19%)

PTON Peloton
$12.24 /

-1.885 (-13.35%)

PLTR Palantir
$7.05 /

-0.41 (-5.50%)

PFE Pfizer
$49.06 /

+0.37 (+0.76%)

NFLX Netflix
$174.36 /

+1.365 (+0.79%)

MTCH Match Group
$68.96 /

-1.77 (-2.50%)

MO Altria Group
$50.90 /

-4.36 (-7.89%)

GOOGL Alphabet Class A
$2,286.31 /

+35.88 (+1.59%)

GOOG Alphabet
$2,295.72 /

+34.43 (+1.52%)

GDRX GoodRx
$7.79 /

-2.96 (-27.53%)

FOXA Fox Corp.
$32.59 /

-0.62 (-1.87%)

FB Meta Platforms
$196.67 /

+0.41 (+0.21%)

DRE Duke Realty
$51.87 /

+4.18 (+8.76%)

DM Desktop Metal
$1.96 /

-1.46 (-42.69%)

CRON Cronos Group
$3.11 /

+0.285 (+10.09%)

C Citi
$48.39 /

-1.51 (-3.03%)

BHC Bausch Health
$9.80 /

-3.11 (-24.09%)

AUPH Aurinia Pharmaceuticals
$10.78 /

+1.83 (+20.45%)

APPN Appian
$54.56 /

+11.55 (+26.85%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.